Project cooperationUpdated on 9 April 2026
Portfolio Company Collaboration: Fina Biosolutions
About
Our carrier protein portfolio includes GMP EcoCRM®(CRM197), Qb (virus-like particles), and Ready-to-Conjugate proteins. We are adding ClickCRM for site-specific click conjugation, and 8MTT, the first commercially available full-length genetically detoxified tetanus toxin. The FinaXpress E. coli expression system is used to make our carrier proteins and can be ideal for working with difficult-to-express proteins. The company has built on its conjugation expertise and now manufactures dextran-based reagents, which are used for flow cytometry, bead modification, and a myriad of other applications. We are interested in meeting with any companies with interest in carrier protein, expression system, or dextran conjugate products.
Stage
- Execution
- Planning
Topic
- Biotech, Pharma and Cosmetics
- Environment
- Food, Beverages and Agriculture
Type
- Research
- Technical
Organisation
Similar opportunities
Project cooperation
- Execution
- Biotech, Pharma and Cosmetics
- Coordinator looking for partners
Renaud Jacquemart
CEO at Omnium Global
Burlington, Canada
Expertise
Connect with Biopharma Experts at the Bioproduction Forum 2026
- Healthcare
- Biotech, Pharma and Cosmetics
Pierre-Mehdi Hammoudi
Scientific Event Manager at MabDesign
Lyon, France
Partnership
R&D collaboration- biocatalysis
Agneya Bhushan
Director of Research and Development at Caravel Bio
Portland, United States